4

OWNERSHIP DOCUMENT

Company: KalVista Pharmaceuticals, Inc.
Filed: October 16, 2017
Period of Report: October 12, 2017
Accession Number: 0001144204-17-052630

View Document ↗ View on SEC.gov ↗